Mariner Investment Group’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

Mariner Investment Group’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,127	Closed	-$10K	–	78
2017 Q2	$10K	Buy	+22,127	New	+$9.43K	0.01%	52

Other funds holding SNOAW

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mariner Investment Group's SNOAW Position: Q3 2017 in Review

Mariner Investment Group sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q3 2017, closing a stake of 22,127 shares — an estimated $10K sold.

Mariner Investment Group first reported a position in SNOAW in Q2 2017 and held it in 1 quarter. The position peaked at $10K in Q2 2017. 2 funds tracked by Wall St. Rank hold SNOAW as of Q3 2017.

Mariner Investment Group reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q3 2017 after selling out during the quarter.
Mariner Investment Group sold 22,127 Sonoma Pharmaceuticals, Inc. Warrants shares in Q3 2017, an estimated $10K.
Mariner Investment Group first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q2 2017 and held it in 1 quarter.
Mariner Investment Group's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $10K in Q2 2017.
2 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q3 2017.

Based on Mariner Investment Group's 13F filing for Q3 2017, filed 1 Nov 2017.